SpendRule Raises $2 Million Seed Round
SpendRule, a Dallas, Texas–based AI-powered contract intelligence platform specifically designed for the healthcare industry, has emerged from stealth with $2 million Seed funding.
The round was led by Abundant Venture Partners, with participation from MemorialCare Innovation Fund and Zeal Capital Partners.
Abundant Venture Partners (AVP) is a Chicago-based purpose-driven venture capital firm and incubator focused on improving the human condition through investments in healthcare, wellness, and performance technology. The firm manages a network of more than 22 healthcare provider organizations that act as co-developers and early adopters for its portfolio companies.
The capital will be used to expand the team and continue development of the company’s AI infrastructure.
Founded by Chris Heckler and Joseph Akintolayo, SpendRule is a healthcare technology company focused on automating contract compliance and invoice validation for hospitals and health systems. The company develops AI-powered contract intelligence software that validates purchased services invoices against contract terms before payment. SpendRule integrates directly with a hospital’s existing enterprise resource planning (ERP) systems, contract management software, and accounts payable workflows. Headquartered in Dallas, Texas, SpendRule serves health systems including OSF HealthCare, Kettering Health, MemorialCare, and MUSC Health.
Funding Details
Company: SpendRule
Raised: $2.0M
Round: Seed
Funding Date: February 2026
Lead Investor: Abundant Venture Partners
Additional Investors: MemorialCare Innovation Fund, Zeal Capital Partners
Company Website: https://spendrule.com/
Software Category: Healthcare AI / Contract Intelligence